These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19152345)

  • 1. LRRK2 G2385R modulates age at onset in Parkinson's disease: A multi-center pooled analysis.
    Tan EK; Peng R; Wu YR; Wu RM; Wu-Chou YH; Tan LC; An XK; Chen CM; Fook-Chong S; Lu CS
    Am J Med Genet B Neuropsychiatr Genet; 2009 Oct; 150B(7):1022-3. PubMed ID: 19152345
    [No Abstract]   [Full Text] [Related]  

  • 2. LRRK2: a link between familial and sporadic Parkinson's disease?
    Lesage S; Dürr A; Brice A
    Pathol Biol (Paris); 2007 Mar; 55(2):107-10. PubMed ID: 16884863
    [No Abstract]   [Full Text] [Related]  

  • 3. The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease.
    Kalinderi K; Fidani L; Bostantjopoulou S; Katsarou Z; Kotsis A
    Eur J Neurol; 2007 Oct; 14(10):1088-90. PubMed ID: 17880562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson's disease compared to late-onset patients.
    Chan DK; Ng PW; Mok V; Yeung J; Fang ZM; Clarke R; Leung E; Wong L
    J Neural Transm (Vienna); 2008 Sep; 115(9):1275-7. PubMed ID: 18523722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease.
    Lu CS; Simons EJ; Wu-Chou YH; Fonzo AD; Chang HC; Chen RS; Weng YH; Rohé CF; Breedveld GJ; Hattori N; Gasser T; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2005 Dec; 11(8):521-2. PubMed ID: 16256409
    [No Abstract]   [Full Text] [Related]  

  • 6. SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson's disease in Chinese population.
    Yang ZH; Li YS; Shi MM; Yang J; Liu YT; Mao CY; Fan Y; Hu XC; Shi CH; Xu YM
    J Neurol; 2019 Jul; 266(7):1796-1800. PubMed ID: 31041581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia.
    Farrer MJ; Stone JT; Lin CH; Dächsel JC; Hulihan MM; Haugarvoll K; Ross OA; Wu RM
    Parkinsonism Relat Disord; 2007 Mar; 13(2):89-92. PubMed ID: 17222580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants ofLRRK2 in Taiwanese Parkinson's disease.
    Wu YR; Chang KH; Chang WT; Hsiao YC; Hsu HC; Jiang PR; Chen YC; Chao CY; Chang YC; Lee BH; Hu FJ; Chen WL; Lee-Chen GJ; Chen CM
    PLoS One; 2013; 8(12):e82001. PubMed ID: 24339985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRRK2 mutations and Parkinsonism.
    Toft M; Mata IF; Kachergus JM; Ross OA; Farrer MJ
    Lancet; 2005 Apr 2-8; 365(9466):1229-30. PubMed ID: 15811454
    [No Abstract]   [Full Text] [Related]  

  • 10. The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease.
    Li C; Ting Z; Qin X; Ying W; Li B; Guo Qiang L; Jian Fang M; Jing Z; Jian Qing D; Sheng Di C
    Mov Disord; 2007 Dec; 22(16):2439-43. PubMed ID: 17960808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.
    Kim JM; Lee JY; Kim HJ; Kim JS; Shin ES; Cho JH; Park SS; Jeon BS
    Parkinsonism Relat Disord; 2010 Feb; 16(2):85-8. PubMed ID: 19854095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lrrk2 p.Q1111H substitution and Parkinson's disease in Latin America.
    Mata IF; Wilhoite GJ; Yearout D; Bacon JA; Cornejo-Olivas M; Mazzetti P; Marca V; Ortega O; Acosta O; Cosentino C; Torres L; Medina AC; Perez-Pastene C; Díaz-Grez F; Vilariño-Güell C; Venegas P; Miranda M; Trujillo-Godoy O; Layson L; Avello R; Dieguez E; Raggio V; Micheli F; Perandones C; Alvarez V; Segura-Aguilar J; Farrer MJ; Zabetian CP; Ross OA
    Parkinsonism Relat Disord; 2011 Sep; 17(8):629-31. PubMed ID: 21632271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common variants of LRRK2 are not associated with sporadic Parkinson's disease.
    Biskup S; Mueller JC; Sharma M; Lichtner P; Zimprich A; Berg D; Wüllner U; Illig T; Meitinger T; Gasser T
    Ann Neurol; 2005 Dec; 58(6):905-8. PubMed ID: 16254973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
    Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
    Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The absence of the common LRRK2 G2019S mutation in 120 young onset Hungarian Parkinon's disease patients].
    Balicza P; Bereznai B; Takáts A; Klivényi P; Dibó G; Hidasi E; Balogh I; Molnár MJ
    Ideggyogy Sz; 2012 Jul; 65(7-8):239-42. PubMed ID: 23074843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LRRK2 gene in Parkinson's disease: mutation screening in patients from Germany.
    Schlitter AM; Woitalla D; Mueller T; Epplen JT; Dekomien G
    J Neurol Neurosurg Psychiatry; 2006 Jul; 77(7):891-2. PubMed ID: 16788020
    [No Abstract]   [Full Text] [Related]  

  • 17. The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population.
    Lu CS; Wu-Chou YH; van Doeselaar M; Simons EJ; Chang HC; Breedveld GJ; Di Fonzo A; Chen RS; Weng YH; Lai SC; Oostra BA; Bonifati V
    Neurogenetics; 2008 Oct; 9(4):271-6. PubMed ID: 18716801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRRK2 G6055A mutation in Italian patients with familial or sporadic Parkinson's disease.
    Civitelli D; Tarantino P; Nicoletti G; Cirò Candiano IC; Annesi F; De Marco EV; Carrideo S; Rocca FE; Condino F; Spadafora P; Pugliese P; D'Asero S; Morelli M; Paglionico S; Annesi G; Quattrone A
    Clin Genet; 2007 Apr; 71(4):367-70. PubMed ID: 17470139
    [No Abstract]   [Full Text] [Related]  

  • 19. LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China.
    Yu L; Hu F; Zou X; Jiang Y; Liu Y; He X; Xi J; Liu L; Liu Z; He L; Xu Y
    Brain Res; 2009 Nov; 1296():113-6. PubMed ID: 19699188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2: bridging the gap between sporadic and hereditary Parkinson's disease.
    Elbaz A
    Lancet Neurol; 2008 Jul; 7(7):562-4. PubMed ID: 18539536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.